<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03577847</url>
  </required_header>
  <id_info>
    <org_study_id>REK 2017/102</org_study_id>
    <nct_id>NCT03577847</nct_id>
  </id_info>
  <brief_title>Rural CT Examination and Thrombolytic Treatment for Stroke</brief_title>
  <acronym>RURALCT</acronym>
  <official_title>Rural CT Examination and Thrombolytic Treatment for Stroke: An Observational Study of Medical and Health Economic Effects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vestre Viken Hospital Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Extrastiftelsen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Vestre Viken Hospital Trust</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To counteract long term sequelae from stroke, ultrarapid diagnosis and treatment, high&#xD;
      quality multidiciplinary in-hospital care and optimal long term rehabilitation is required.&#xD;
      In this study, the investigators are moving the essential first diagnosis and treatment out&#xD;
      into the community close to where the patient live, thus shortening the all important time&#xD;
      from debut of symptoms to thrombolytic treatment improving the prognosis of stroke patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Stroke is an acute, potentially mutilating disease. To counteract long term sequelae three&#xD;
      factors are essential: Ultrarapid diagnosis and treatment, high quality multidiciplinary&#xD;
      in-hospital care and optimal long term rehabilitation. Initial diagnosis and treatment has up&#xD;
      to now been completed within the hospital domain. This study will change that: moving the&#xD;
      essential first diagnosis and treatment out into the community close to where the patient&#xD;
      lives thus shortening the all important time from debut of symptoms to thrombolytic&#xD;
      treatment. We will operate a local computer tomography (CT) service in the hands of community&#xD;
      based non-specialized health care personnel (MD and nurse) acting under direct telemetric&#xD;
      guidance from on call hospital specialists. Thus, the investigators will show that by&#xD;
      combining current technological advances in real time video communication with an acutely&#xD;
      well functioning cooperation between the community and hospital health service personnel the&#xD;
      prognosis of stroke patients is improved.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">November 20, 2017</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Actual">April 7, 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>3 Months</target_duration>
  <primary_outcome>
    <measure>Thrombolytic treatment</measure>
    <time_frame>3 months</time_frame>
    <description>The proportion of patients with ischaemic stroke receiving thrombolytic treatment in percent.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ictus to needle time</measure>
    <time_frame>3 months</time_frame>
    <description>Time from onset of stroke symptoms (Ictus) to thrombolytic treatment (Needle).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional status</measure>
    <time_frame>3 months</time_frame>
    <description>Modified Rankin Scale (mRS score 0-6). Good outcome 0-2</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cognitive status</measure>
    <time_frame>3 months</time_frame>
    <description>Montreal Cognitive Assessment (MoCA score 0-30). Good outcome 26-30</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depression</measure>
    <time_frame>3 months</time_frame>
    <description>Geriatric depression scale (GDS score 0-30). Good outcome 0-10</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>Intervention group: Stroke patients investigated with rural CT scanning at HSS, Ål. Patients living in the municipalities of Hol, Ål, Gol, Hemsedal and Nes.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <description>Control-group: Stroke patients with similar transportation time to hospital, but no access to rural CT scanning. Patients living in the municipalities of Nore- and Uvdal, Vang, Øystre and Vestre Slidre, Lesja, Vågå, Lom, Dovre, Skjåk and Sel.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Rural CT scanning</intervention_name>
    <description>Rural computer tomography for acute stroke</description>
    <arm_group_label>1</arm_group_label>
    <other_name>Thrombolysis</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Intervention group (access to local CT):&#xD;
&#xD;
        Patients from the municipalities Hol, Ål, Gol, Hemsedal and Nes.&#xD;
&#xD;
        Control group (no local CT):&#xD;
&#xD;
        Patients from the municipalities Nore and Uvdal, Vang, Øystre- and Vestre Slidre, Lesja,&#xD;
        Skjåk, Lom, Dovre, Vågå and Sel.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patients over 18 years being investigated by CT within 24 hours for acute symptoms of&#xD;
             stroke.&#xD;
&#xD;
          2. Fullfilling criteria for the diagnosis acute stroke as described by the Norwegian&#xD;
             stroke registry.&#xD;
&#xD;
          3. Giving informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Symptoms not due to ischaemic or haemorrhagic stroke as adjudicated at discharge.&#xD;
&#xD;
          2. Not able to cooperate to 3 months follow up.&#xD;
&#xD;
          3. Not giving informed consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jorgen M Ibsen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vestre Viken Hospital Trust</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Vestre Viken Hospital Trust</name>
      <address>
        <city>Honefoss</city>
        <state>Buskerud</state>
        <zip>3004</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>January 9, 2018</study_first_submitted>
  <study_first_submitted_qc>June 22, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 5, 2018</study_first_posted>
  <last_update_submitted>April 13, 2021</last_update_submitted>
  <last_update_submitted_qc>April 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Stroke, Thrombolysis, Rural CT</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

